Войти в систему Зарегистрироваться бесплатно

QSAM Biosciences Операционная прибыль

Что обозначает Операционная прибыль в QSAM Biosciences?

Операционная прибыль QSAM Biosciences, Inc. является 0.00%

Какое определение для Операционная прибыль?



Показатель относительной доходности компании - это отношение операционной прибыли, деленной на чистую выручку и выраженной в процентах.

Operating margin is an indicator of profitability and is often used to compare the profitability of companies and industries of differing sizes. Companies are collections of projects and markets, individual areas can be judged on how successful they are at adding to the corporate net profit. Not all projects are of equal size, however, and one way to adjust for size is to divide the profit by sales revenue. The resulting ratio is the percentage of sales revenue that gets 'returned' to the company as net profits after all the related costs of the activity are deducted.

Операционная прибыль компаний в Health Care сектор на OTC по сравнению с QSAM Biosciences

Что делает QSAM Biosciences?

QSAM Biosciences, Inc., a clinical stage biotechnology company, develops drugs for the treatment of bone cancer. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage novel radiopharmaceutical for the treatment of bone cancer and related diseases. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc. and changed its name to QSAM Biosciences, Inc. in September 2020. QSAM Biosciences, Inc. was founded in 2004 and is based in Austin, Texas.

Компании с операционная прибыль похож на QSAM Biosciences